SAN JOSE — The U.S. Food and Drug Administration has indicated that Onglyza and other diabetes drugs can cause severe and debilitating joint pain in drug users.

NBC News – San Jose reports that while the drugs have already been known to cause severe side-effects including Onglyza related heart failure, this is the first occurrence of joint pain being widely acknowledged as a major health complication.

In a statement issued to the public, the FDA said:

“The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling. We Have added a new Warning and Precaution about this risk to the labels of all medicines in this drug class, called dipeptidyl peptidase-4 (DPP-4) inhibitors.”

While the FDA has noted that side-effects can be caused by other factors besides drug use, their analysis indicated that Onglyza users face a heightened risk of developing severe joint pain. However, the FDA has yet to announce a recall or need to immediately halt the use of Onglyza, rather:

“Patients should not stop taking their DPP-4 inhibitor medicine, but should contact their health care professional right away if they experience severe and persistent joint pain.”

Our No Fee Promise on Onglyza Cases

You can afford to have our great team of Onglyza lawyers on your side. If you choose us, it literally costs you nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive an Onglyza settlement
  • Phone calls are always free

Start Your Onglyza Lawsuit Claim

Our Onglyza lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Onglyza lawsuit claims.